Nonsteroidal anti-inflammatory drug use is associated with cancer risk reduction in chronic dialysis patients

Shuo Ming Ou, Yung Tai Chen, Pei Wen Chao, Yi Jung Lee, Chia Jen Liu, Chiu Mei Yeh, Tzeng Ji Chen, Tzen Wen Chen, Wu Chang Yang, Szu Yuan Li

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Previous studies have shown that nonsteroidal anti-inflammatory drug (NSAID) use might be associated with a lower risk of developing cancer in the general population. Patients on dialysis have increased risk for cancer, but there are no studies to determine the relationship between NSAID use and cancer risk in these patients. To identify any association between NSAID use and cancer risk in patients with end-stage renal disease on dialysis, we used Taiwan's National Health Insurance database to conduct a nationwide population-based, propensity score-matched cohort study. All cancers between groups were compared by Cox proportional hazards models. Compared to nonuse of NSAIDs, the use of non-COX-2-selective inhibitors (hazard ratio 0.81, 95% confidence interval 0.67-0.97) or COX-2-selective inhibitors (0.78, 0.62-0.98) was associated with a lower risk of developing cancer. NSAID use reduced the risk of respiratory (0.39, 0.19-0.79), breast (0.41, 0.19-0.89), kidney (0.58, 0.38-0.88), digestive tract (0.64, 0.49-0.85), and bladder cancers (0.73, 0.55-0.96). NSAID use, however, significantly increased risk for upper gastrointestinal bleeding (odds ratio, 1.15, 1.07-1.23) but not adverse cardiac or cerebrovascular events. Thus, NSAID use was associated with a lower risk of developing cancer in chronic dialysis patients; however, they should still be used with caution due to the side effects of gastrointestinal bleeding.

Original languageEnglish
Pages (from-to)198-205
Number of pages8
JournalKidney International
Volume84
Issue number1
DOIs
Publication statusPublished - Jul 2013

Fingerprint

Risk Reduction Behavior
Dialysis
Anti-Inflammatory Agents
Pharmaceutical Preparations
Neoplasms
Hemorrhage
Propensity Score
Cyclooxygenase 2 Inhibitors
National Health Programs
Non-Steroidal Anti-Inflammatory Agents
Taiwan
Proportional Hazards Models
Urinary Bladder Neoplasms
Population
Chronic Kidney Failure
Gastrointestinal Tract
Breast
Cohort Studies
Odds Ratio
Databases

ASJC Scopus subject areas

  • Nephrology

Cite this

Nonsteroidal anti-inflammatory drug use is associated with cancer risk reduction in chronic dialysis patients. / Ou, Shuo Ming; Chen, Yung Tai; Chao, Pei Wen; Lee, Yi Jung; Liu, Chia Jen; Yeh, Chiu Mei; Chen, Tzeng Ji; Chen, Tzen Wen; Yang, Wu Chang; Li, Szu Yuan.

In: Kidney International, Vol. 84, No. 1, 07.2013, p. 198-205.

Research output: Contribution to journalArticle

Ou, SM, Chen, YT, Chao, PW, Lee, YJ, Liu, CJ, Yeh, CM, Chen, TJ, Chen, TW, Yang, WC & Li, SY 2013, 'Nonsteroidal anti-inflammatory drug use is associated with cancer risk reduction in chronic dialysis patients', Kidney International, vol. 84, no. 1, pp. 198-205. https://doi.org/10.1038/ki.2013.79
Ou, Shuo Ming ; Chen, Yung Tai ; Chao, Pei Wen ; Lee, Yi Jung ; Liu, Chia Jen ; Yeh, Chiu Mei ; Chen, Tzeng Ji ; Chen, Tzen Wen ; Yang, Wu Chang ; Li, Szu Yuan. / Nonsteroidal anti-inflammatory drug use is associated with cancer risk reduction in chronic dialysis patients. In: Kidney International. 2013 ; Vol. 84, No. 1. pp. 198-205.
@article{d653609978ba439986c162794c93f8d5,
title = "Nonsteroidal anti-inflammatory drug use is associated with cancer risk reduction in chronic dialysis patients",
abstract = "Previous studies have shown that nonsteroidal anti-inflammatory drug (NSAID) use might be associated with a lower risk of developing cancer in the general population. Patients on dialysis have increased risk for cancer, but there are no studies to determine the relationship between NSAID use and cancer risk in these patients. To identify any association between NSAID use and cancer risk in patients with end-stage renal disease on dialysis, we used Taiwan's National Health Insurance database to conduct a nationwide population-based, propensity score-matched cohort study. All cancers between groups were compared by Cox proportional hazards models. Compared to nonuse of NSAIDs, the use of non-COX-2-selective inhibitors (hazard ratio 0.81, 95{\%} confidence interval 0.67-0.97) or COX-2-selective inhibitors (0.78, 0.62-0.98) was associated with a lower risk of developing cancer. NSAID use reduced the risk of respiratory (0.39, 0.19-0.79), breast (0.41, 0.19-0.89), kidney (0.58, 0.38-0.88), digestive tract (0.64, 0.49-0.85), and bladder cancers (0.73, 0.55-0.96). NSAID use, however, significantly increased risk for upper gastrointestinal bleeding (odds ratio, 1.15, 1.07-1.23) but not adverse cardiac or cerebrovascular events. Thus, NSAID use was associated with a lower risk of developing cancer in chronic dialysis patients; however, they should still be used with caution due to the side effects of gastrointestinal bleeding.",
author = "Ou, {Shuo Ming} and Chen, {Yung Tai} and Chao, {Pei Wen} and Lee, {Yi Jung} and Liu, {Chia Jen} and Yeh, {Chiu Mei} and Chen, {Tzeng Ji} and Chen, {Tzen Wen} and Yang, {Wu Chang} and Li, {Szu Yuan}",
year = "2013",
month = "7",
doi = "10.1038/ki.2013.79",
language = "English",
volume = "84",
pages = "198--205",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Nonsteroidal anti-inflammatory drug use is associated with cancer risk reduction in chronic dialysis patients

AU - Ou, Shuo Ming

AU - Chen, Yung Tai

AU - Chao, Pei Wen

AU - Lee, Yi Jung

AU - Liu, Chia Jen

AU - Yeh, Chiu Mei

AU - Chen, Tzeng Ji

AU - Chen, Tzen Wen

AU - Yang, Wu Chang

AU - Li, Szu Yuan

PY - 2013/7

Y1 - 2013/7

N2 - Previous studies have shown that nonsteroidal anti-inflammatory drug (NSAID) use might be associated with a lower risk of developing cancer in the general population. Patients on dialysis have increased risk for cancer, but there are no studies to determine the relationship between NSAID use and cancer risk in these patients. To identify any association between NSAID use and cancer risk in patients with end-stage renal disease on dialysis, we used Taiwan's National Health Insurance database to conduct a nationwide population-based, propensity score-matched cohort study. All cancers between groups were compared by Cox proportional hazards models. Compared to nonuse of NSAIDs, the use of non-COX-2-selective inhibitors (hazard ratio 0.81, 95% confidence interval 0.67-0.97) or COX-2-selective inhibitors (0.78, 0.62-0.98) was associated with a lower risk of developing cancer. NSAID use reduced the risk of respiratory (0.39, 0.19-0.79), breast (0.41, 0.19-0.89), kidney (0.58, 0.38-0.88), digestive tract (0.64, 0.49-0.85), and bladder cancers (0.73, 0.55-0.96). NSAID use, however, significantly increased risk for upper gastrointestinal bleeding (odds ratio, 1.15, 1.07-1.23) but not adverse cardiac or cerebrovascular events. Thus, NSAID use was associated with a lower risk of developing cancer in chronic dialysis patients; however, they should still be used with caution due to the side effects of gastrointestinal bleeding.

AB - Previous studies have shown that nonsteroidal anti-inflammatory drug (NSAID) use might be associated with a lower risk of developing cancer in the general population. Patients on dialysis have increased risk for cancer, but there are no studies to determine the relationship between NSAID use and cancer risk in these patients. To identify any association between NSAID use and cancer risk in patients with end-stage renal disease on dialysis, we used Taiwan's National Health Insurance database to conduct a nationwide population-based, propensity score-matched cohort study. All cancers between groups were compared by Cox proportional hazards models. Compared to nonuse of NSAIDs, the use of non-COX-2-selective inhibitors (hazard ratio 0.81, 95% confidence interval 0.67-0.97) or COX-2-selective inhibitors (0.78, 0.62-0.98) was associated with a lower risk of developing cancer. NSAID use reduced the risk of respiratory (0.39, 0.19-0.79), breast (0.41, 0.19-0.89), kidney (0.58, 0.38-0.88), digestive tract (0.64, 0.49-0.85), and bladder cancers (0.73, 0.55-0.96). NSAID use, however, significantly increased risk for upper gastrointestinal bleeding (odds ratio, 1.15, 1.07-1.23) but not adverse cardiac or cerebrovascular events. Thus, NSAID use was associated with a lower risk of developing cancer in chronic dialysis patients; however, they should still be used with caution due to the side effects of gastrointestinal bleeding.

UR - http://www.scopus.com/inward/record.url?scp=84879688027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879688027&partnerID=8YFLogxK

U2 - 10.1038/ki.2013.79

DO - 10.1038/ki.2013.79

M3 - Article

C2 - 23486520

AN - SCOPUS:84879688027

VL - 84

SP - 198

EP - 205

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 1

ER -